Mary Rinella

Appearances

NEW SAFETY AND EFFICACY ANALYSES FROM THE REGENERATE TRIAL OF OBETICHOLIC ACID FOR THE TREATMENT OF NONALCOHOLIC STEATOHEPATITIS
Date
May 7, 2023
Background: Nonalcoholic steatohepatitis (NASH) is a major cause of liver-related morbidity, mortality, and the leading indication for liver transplant in the US. Fibrosis is the best predictor of clinical outcomes in NASH…
Presenter
Mary Rinella
Speakers
Arun Sanyal
Rohit Loomba
Quentin Anstee
Vlad Ratziu
Kris Kowdley
Eric Lawitz
Manal Abdelmalek
M. Michelle Berrey
Christopher White
Steven Shiff
Sangeeta Sawhney
Thomas Capozza
Rina Leyva
Stephen A. Harrison
Zobair Younossi
OVERVIEW OF THE DELPHI PROCESS AND KEY FINDINGS
Date
May 6, 2023
SOCIETY: AASLD
Presenter
Mary Rinella
CLINICAL ASSESSMENT AND MANAGEMENT OF NONALCOHOLIC FATTY LIVER DISEASE
Date
May 8, 2023
SOCIETY: AASLD
Presenter
Mary Rinella
ACHIEVING MORE EQUITABLE ALLOCATION OF DONOR LIVER GRAFTS THROUGH BALANCING SURVIVAL AND MEDICAL URGENCY: A NOVEL MATHEMATICAL MODEL MONALISA 1.0
Date
May 6, 2023
BACKGROUND: Organ allocation based on the principles of urgency vs utility presents an ethical conundrum given the scarcity of liver grafts…
Speakers
Nicholas Syn
Wen Hui Lim
Cheng Han Ng
Darren Tan
Rebecca Wenling Zeng
Mark Muthiah
Daniel Huang
Eunice Tan
Karn Wijarnpreecha
Michael Tseng
Philip Vutien
Veeral Ajmera
University of California San Diego
Mary Rinella
Mazen Noureddin
Mohammad Shadab Siddiqui
Presenter
Jieling Xiao
NITS IN CURRENT CLINICAL PRACTICE FOR NAFLD: USES AND CAVEATS
Date
May 6, 2023
SOCIETY: AASLD
Speakers
Mary Rinella
Alina Allen
Mayo Clinic
Presenter
Michael Charlton
JUDGES
Date
May 20, 2024
Presenters
Mary Rinella
Rotonya Carr
University of Washington
Rohit Kohli
Children's Los Angeles